Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss
Year: 2009
Type: review
Source: Diabetes Obesity and Metabolism
Authors: S. Jacob, M. Rabbia, M. K. Meier, J. Hauptman
Institution: F. Hoffmann-La Roche AG
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1988187729
